Surv Biopharma
Tokyo, Japan· Est.
A Japanese biopharmaceutical company developing novel antibody-based therapeutics, primarily focused on treatments for cancer and autoimmune diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
About
A Japanese biopharmaceutical company developing novel antibody-based therapeutics, primarily focused on treatments for cancer and autoimmune diseases.
OncologyImmunologyAntibodies